Spectrofluorimetric analysis of famotidine in pharmaceutical preparations and biological fluids by derivatization with benzoin

Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy

Volumn 134, Issue , 2015, Pages 449-452

  Alamgir, Malik ^a   Khuhawar, Muhammad Yar ^a   Memon, Saima Q ^a   Hayat, Amir ^a   Zounr, Rizwan Ali ^a  

^a UNIVERSITY OF SINDH   (Pakistan)

Author keywords

Benzoin; Deproteinized; Derivatization; Famotidine; Serum and urine

Indexed keywords

ADDITIVES;

BENZOIN; DEPROTEINIZED; DERIVATIZATIONS; FAMOTIDINE; SERUM AND URINE;

FLUORESCENCE;

BENZOIN; FAMOTIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST;

BLOOD; CHEMISTRY; EVALUATION STUDY; HUMAN; LIMIT OF DETECTION; PROCEDURES; SPECTROFLUOROMETRY; URINE;

BENZOIN; FAMOTIDINE; HISTAMINE H2 ANTAGONISTS; HUMANS; LIMIT OF DETECTION; SPECTROMETRY, FLUORESCENCE;

EID: 84904287846     PISSN: 13861425     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.saa.2014.06.118     Document Type: Article

References (25)

1. L. Zhang, and K.C. Yeh J. Pharm. Biomed. Anal. 16 1998 1051 1057
2. J.E.F. Raynolds Martindale: The Extra Pharmacopeia 23rd ed. 1999 The Pharmaceutical Press Massachusetts
3. Z. Zarghi, A. Shafaati, S.M. Foroutan, and A. Khoddan J. Pharm. Biomed. Anal. 39 2005 677 680
4. M. Apostu, N. Bibire, and V. Dorneanu Med. Nat. Iasi. 109 2005 422 425
5. N. Rahman, and M. Kashif Farmaco 58 2003 1045 1050
6. N. Rahman, and M. Kashif Anal. Sci. 19 2003 907 911
7. S. Al-Ghannam, and F. Belal J. AOAC Int. 85 2002 1003 1008
8. M.I. Walash, M.K. Sharaf-El-Din, M.E. Metwally, and M.R. Shabana J. Chin. Soc. A 52 2005 71 76
9. The British Pharmacopeia, The Stationary Office, London, 2008, p897.
10. M.I. Walash, M.K. Sharaf-El-Din, M.E. Metwally, and M.R. Shabana J. Chin. Soc. A 52 2005 927 953
11. M.I. Walash, A. El-Brashy, N. El-Enany, and M.E. Kamel J. Fluorescence 19 2009 333 344
12. S.A. Abdel Kader, M.A. Abdel Kawy, and M. Nebron Anal. Lett. 32 1999 1403 1419
13. A. El-Bayoumi, A.A. Al-Shanawany, M.E. El-Sadek, and A. Abd-El-Satter Spectrosc. Lett. 30 1997 25 26
14. M.I. Walash, A. El-Brashy, N. El-Enany, and M.E.K. Wahba Int. J. Biomed. Sci. 5 2009 158 168
15. N. Helali, and L. Monser J. Sep. Sci. 31 2008 276 282
16. D.A. Ashira, R. Patel, and A. Basit J. Chromatogr. B 860 2007 235 240
17. A. Zarghi, A. Shafaati, S.M. Foroutam, and A. Khoddam J. Pharm. Biomed. Anal. 39 2005 677 680
18. M.A. Campanero, I. Bueno, M.A. Arangoa, M. Escolar, E.G. Quetglas, A. Lopez-Ocariz, and J.R. Azanza J. Chromatogr., B: Anal. Technol. Biomed. Life Sci. 763 2001 21 23
19. L. Zhang, R. Eisenhandler, and K.C. Yeh J. Mass Spectrom. 36 2001 736 744
20. N. Helali, N. Abhoum, and L. Monser J. Flow Injection Anal. 22 2005 129 133
21. P.D. Tzanavaras, A. Verdoukas, and T. Balloma J. Pharm. Biomed. Anal. 39 2005 437 441
22. N. Helali, N.T. Tram, L. Monser, and M. Taverna Talanta 74 2008 694 698
23. S.A. Majedano, and M.Y. Khuhawar Chromatographia 75 2012 1311 1317
24. M. Alamgir, M.Y. Khuhawar, A. Hayat, and A.A. Majidano Int. J. Adv. Res. 1 2013 549 555
25. Guidance for Industry, Q2B Validation of Analytical Procedures: Methodology, International Conference on Harmonization (ICH). < http://www.fda.gov/eder/guidance/1320fnl >, 1996 (accessed on 03-07-2014).